Clinical and biochemical features of some intravenous iron complexes

Yazar: S. Yu. Abashin, E. N. Misyurina, E. I. Zhelnova, A. V. Misyurin
Baskı/Yayın Bilgisi 2014-07-01

Acellbia® and Mabtera® are recognize CD20-positive cells with equal efficiency

Yazar: V. A. Misyurin, A. V. Misyurin, A. E. Misyurina, Yu. P. Finashutina, M. A. Baryshnikovа, O. S. Burova, S. K. Kravchenko
Baskı/Yayın Bilgisi 2015-12-01

Mutation status of refractory to imatinib patients with chronic myeloid leukemia

Yazar: E. G. Ovsyannikova, K. D. Kaplanov, T. Yu. Klitochenko, A. V. Misyurin, I. L. Davydkin, L. V. Zaklyakova, E. A. Popov, B. N. Levitan
Baskı/Yayın Bilgisi 2014-07-01

Chemoresistance of PRAME-expressing melanoma cell can be resolved with help of bortezomib

Yazar: V. A. Misyurin, D. V. Kalenichenko, A. A. Rudakova, Yu. P. Finashutina, N. A. Lyzhko, V. V. Tikhonova, L. A. Kesaeva, O. N. Solopova, A. Е. Misyurina, A. N. Velikanov, M. А. Baryshnikovа, A. V. Misyurin
Baskı/Yayın Bilgisi 2019-01-01

Comparison of molecular genetic methods of detection of mutations in the CALR gene in myeloproliferative disorders

Yazar: L. A. Kesaeva, A. Yu. Bulanov, Yu. P. Finashutina, V. V. Tikhonova, O. N. Solopova, E. N. Misyurina, N. N. Kasatkina, N. A. Lyzhko, V. A. Misyurin, A. A. Turba, A. A. Solodovnik, I. N. Soldatova, A. V. Misyurin
Baskı/Yayın Bilgisi 2019-07-01

EXPRESSION OF CANCER-TESTIS GENES PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 IN PATIENTS WITH MULTIPLE MYELOMA, THEIR INFLUENCE ON OVERALL SURVIVAL AND R...

Yazar: A. A. Solodovnik, H. S. Mkrtchyan, V. A. Misyurin, V. V. Tikhonova, Yu. P. Finashutina, N. N. Kasatkina, O. N. Solopova, O. M. Votyakova, O. Yu. Yakimovich, O. M. Volodina, M. Yu. Kichigina, E. G. Medvedovskaya, A. S. Antipova, I. Z. Zavodnova, A. A. Semenova, G. R. Arakelyan, Yu. E. Ryabukhina, O. A. Kolomeytsev, A. D. Shirin, E. A. Osmanov, A. V. Misyurin
Baskı/Yayın Bilgisi 2018-07-01

Translocation t(1;11)(p32;q23) with MLL-EPS15 fusion gene formation in acute leukemias: a review and 6 new case reports. Approaches to minimal residual disease monitoring

Yazar: G. A. Tsaur, A. M. Popov, O. M. Plekhanova, A. M. Kustanovich, O. V. Aleynikova, T. L. Gindina, A. S. Demina, A. Ye. Druy, S. Yu. Kovalev, K. L. Kondratchik, A. V. Misyurin, N. V. Myakova, T. O. Riger, L. I. Savelyev, O. I. Sokova, O. V. Streneva, M. V. Suchkova, Yu. P. Finashutina, Ye. V. Fleyshman, Ye. V. Shorikov, R. I. Yutskevich, C. Meyer, R. Marschalek, L. G. Fechina
Baskı/Yayın Bilgisi 2014-07-01

Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase

Yazar: Ol'ga Yur'evna Vinogradova, Anna Grigor'evna Turkina, Aleksandra Valer'evna Vorontsova, Ekaterina Yur'evna Chelysheva, Galina Anatol'evna Gusarova, S V Kuznetsov, Svetlana Rudol'fovna Goryacheva, Manana Aleksandrovna Sokolova, Evgeniy Mikhaylovich Abakumov, Ol'ga Veniaminovna Stakhina, Elena Vasil'evna Domracheva, Andrey Vital'evich Misyurin, Nina Dmitrievna Khoroshko, O Yu Vinogradova, A G Turkina, A V Vorontsova, E Yu Chelysheva, G A Gusarova, S V Kuznetsov, S R Goryacheva, M A Sokolova, E M Abakumov, O V Stakhina, E V Domracheva, A V Misyurin, N D Khoroshko
Baskı/Yayın Bilgisi 2009-07-01